Stemline Therapeutics Announces Proposed Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
Stemline Therapeutics (STML) Prices 3.8M Common Offering at $15.75/Share
January 8, 2015 9:06 AM ESTStemline Therapeutics (Nasdaq: STML) announced the pricing of its previously announced underwritten public offering of 3,800,000 shares of its common stock at a public offering price of $15.75 per share. Stemline has also granted the underwriters a 30-day option to purchase up to an additional 570,000... More
Stemline Therapeutics (STML) Plans Common Stock Offering
January 7, 2015 4:09 PM ESTStemline Therapeutics (NASDAQ: STML) athat it intends to offer and sell shares of its common stock in an underwritten public offering. Stemline expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered... More

